Elizabeth A. Lilly

1.3k total citations
31 papers, 1.1k citations indexed

About

Elizabeth A. Lilly is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Periodontics. According to data from OpenAlex, Elizabeth A. Lilly has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Public Health, Environmental and Occupational Health and 8 papers in Periodontics. Recurrent topics in Elizabeth A. Lilly's work include Antifungal resistance and susceptibility (12 papers), HIV/AIDS oral health manifestations (9 papers) and Immune responses and vaccinations (7 papers). Elizabeth A. Lilly is often cited by papers focused on Antifungal resistance and susceptibility (12 papers), HIV/AIDS oral health manifestations (9 papers) and Immune responses and vaccinations (7 papers). Elizabeth A. Lilly collaborates with scholars based in United States, Canada and Vietnam. Elizabeth A. Lilly's co-authors include Paul L. Fidel, Mairi C. Noverr, Melphine Harriott, Junko Yano, Brian M. Peters, Melissa M. Barousse, Andrea K. Nash, Glen E. Palmer, Janet E. Leigh and Shannon K. Esher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Elizabeth A. Lilly

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth A. Lilly United States 18 675 457 238 225 189 31 1.1k
Eric F. Kong United States 12 752 1.1× 265 0.6× 194 0.8× 490 2.2× 46 0.2× 14 1.3k
Maria Simitsopoulou Greece 21 978 1.4× 748 1.6× 97 0.4× 275 1.2× 144 0.8× 56 1.3k
Andreas Pikis United States 21 414 0.6× 956 2.1× 107 0.4× 259 1.2× 101 0.5× 36 1.7k
Pierre Kyme United States 14 247 0.4× 142 0.3× 135 0.6× 250 1.1× 172 0.9× 17 893
Daniel Montelongo‐Jauregui United States 15 637 0.9× 257 0.6× 113 0.5× 294 1.3× 28 0.1× 21 1.1k
Andrea Maria Schmidt‐Westhausen Germany 20 538 0.8× 418 0.9× 40 0.2× 148 0.7× 50 0.3× 40 1.2k
Ashley Keller United States 16 267 0.4× 204 0.4× 172 0.7× 542 2.4× 331 1.8× 29 1.4k
Claudia Trappetti Australia 20 184 0.3× 893 2.0× 472 2.0× 431 1.9× 93 0.5× 39 1.5k
M A Ghannoum United States 15 869 1.3× 772 1.7× 74 0.3× 156 0.7× 55 0.3× 15 1.2k
Graeme A. O’May United Kingdom 7 287 0.4× 125 0.3× 154 0.6× 523 2.3× 46 0.2× 7 922

Countries citing papers authored by Elizabeth A. Lilly

Since Specialization
Citations

This map shows the geographic impact of Elizabeth A. Lilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Lilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Lilly more than expected).

Fields of papers citing papers by Elizabeth A. Lilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Lilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Lilly. The network helps show where Elizabeth A. Lilly may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Lilly

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Lilly. A scholar is included among the top collaborators of Elizabeth A. Lilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Lilly. Elizabeth A. Lilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Esher, Shannon K., et al.. (2022). Efficacy of Candida dubliniensis and Fungal β-Glucans in Inducing Trained Innate Immune Protection Against Inducers of Sepsis. Frontiers in Cellular and Infection Microbiology. 12. 898030–898030. 17 indexed citations
3.
Fidel, Paul L., Elizabeth A. Lilly, Shahr B. Hashmi, et al.. (2021). Effect of HIV/HAART and Other Clinical Variables on the Oral Mycobiome Using Multivariate Analyses. mBio. 12(2). 21 indexed citations
4.
5.
Yano, Junko, Elizabeth A. Lilly, Mairi C. Noverr, & Paul L. Fidel. (2020). A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model. Journal of Visualized Experiments. 5 indexed citations
6.
Yano, Junko, Elizabeth A. Lilly, Mairi C. Noverr, & Paul L. Fidel. (2020). A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model. Journal of Visualized Experiments. 1 indexed citations
7.
Griffen, Ann L., Clifford J. Beall, Elizabeth A. Lilly, et al.. (2019). Significant effect of HIV/HAART on oral microbiota using multivariate analysis. Scientific Reports. 9(1). 19946–19946. 25 indexed citations
8.
Wang, Yapin, Elizabeth A. Lilly, Thomas E. Lallier, et al.. (2017). Synthesis, Antifungal Activity, and Biocompatibility of Novel 1,4-Diazabicyclo[2.2.2]Octane (DABCO) Compounds and DABCO-Containing Denture Base Resins. Antimicrobial Agents and Chemotherapy. 61(4). 16 indexed citations
9.
Peters, Brian M., et al.. (2016). A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response. PLoS ONE. 11(1). e0147969–e0147969. 35 indexed citations
10.
Fidel, Paul L. & Elizabeth A. Lilly. (2015). Activity of TOL-463 Against Biofilms Formed by Candida Species in an Ex Vivo Murine Vaginitis Model. Open Forum Infectious Diseases. 2(suppl_1). 1 indexed citations
11.
Lilly, Elizabeth A., et al.. (2011). Fabrication of a multi‐applicable removable intraoral denture system for rodent research. Journal of Oral Rehabilitation. 38(9). 686–690. 22 indexed citations
12.
Lilly, Elizabeth A., Junko Yano, & Paul L. Fidel. (2010). Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety. Molecular Oral Microbiology. 25(4). 293–304. 21 indexed citations
13.
Harriott, Melphine, et al.. (2010). Candida albicans forms biofilms on the vaginal mucosa. Microbiology. 156(12). 3635–3644. 229 indexed citations
14.
Lilly, Elizabeth A., et al.. (2006). Candida-induced Oral Epithelial Cell Responses. Mycopathologia. 162(1). 25–32. 9 indexed citations
15.
Mercante, Donald E., et al.. (2006). Assessment of the Association Between HIV Viral Load and CD4 Cell Count on the Occurrence of Oropharyngeal Candidiasis in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(5). 578–583. 17 indexed citations
16.
Lilly, Elizabeth A., et al.. (2005). Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions. Oral Microbiology and Immunology. 20(3). 154–162. 22 indexed citations
17.
Yano, Junko, Elizabeth A. Lilly, Chad Steele, Dennis J. Fortenberry, & Paul L. Fidel. (2005). Oral and vaginal epithelial cell anti‐Candida activity is acid labile and does not require live epithelial cells. Oral Microbiology and Immunology. 20(4). 199–205. 26 indexed citations
18.
Lilly, Elizabeth A., et al.. (2005). Oral epithelial cell antifungal activity: approaches to evaluate a broad range of clinical conditions. Medical Mycology. 43(6). 517–523. 4 indexed citations
19.
Lilly, Elizabeth A., et al.. (2004). Tissue‐Associated Cytokine Expression in HIV‐Positive Persons with Oropharyngeal Candidiasis. The Journal of Infectious Diseases. 190(3). 605–612. 21 indexed citations
20.
Leigh, Janet E., et al.. (2003). Immunohistochemical Evaluation of T Cells in Oral Lesions from Human Immunodeficiency Virus-Positive Persons with Oropharyngeal Candidiasis. Infection and Immunity. 71(2). 956–963. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric F. Kong Breakdown of academic impact, for papers by Maria Simitsopoulou Breakdown of academic impact, for papers by Andreas Pikis Breakdown of academic impact, for papers by Pierre Kyme Breakdown of academic impact, for papers by Daniel Montelongo‐Jauregui Breakdown of academic impact, for papers by Andrea Maria Schmidt‐Westhausen Breakdown of academic impact, for papers by Ashley Keller Breakdown of academic impact, for papers by Claudia Trappetti Breakdown of academic impact, for papers by M A Ghannoum Breakdown of academic impact, for papers by Graeme A. O’May
Rankless by CCL
2026